How to Buy Opus Genetics Stock
Opus Genetics Inc
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology.
Opus Genetics stock last closed at $4.07, up 0.25% from the previous day, and has increased 337.16% in one year. It has overperformed other stocks in the Biotechnology industry by 4.09 percentage points. Opus Genetics stock is currently +351.72% from its 52-week low of $0.90, and -29.95% from its 52-week high of $5.81.
As of Jun 18, 2026, there are 81.4M shares of IRD outstanding. The market capitalization of IRD is $331.28M. In the last 24 hours, 1.06M IRD shares were traded.
How to Buy Opus Genetics Stock
Wondering how to invest in Opus Genetics stock? Here's how.
- Choose where to buy Opus Genetics stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you figure out where to buy Opus Genetics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Pick your payment method and add your details.
- Research Opus Genetics stock: The Opus Genetics ticker symbol is IRD. Is Opus Genetics stock a good investment? Should you buy shares of IRD? How do IRD's underlying business fundamentals look? Do top analysts think Opus Genetics is a good buy? Why has IRD's stock price moved recently? (Hint: Our stock analysis website can help you decide if IRD is a good stock to buy).
- Place your IRD buy order: Decide if you will purchase IRD shares at the current market price or use a limit order to purchase IRD stock at a given price.
- Get the latest news on your IRD investment: Create a watchlist to monitor your position in Opus Genetics stock.
Step 1: Choose where to buy Opus Genetics stock
You will need an online brokerage account in order to access the NASDAQ market and buy IRD stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal information so you can invest in IRD today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have opened your account on one of the most highly reviewed stock apps, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring funds into your new investment account.
Step 4: Research Opus Genetics stock
After you have identified the best place to buy Opus Genetics stock, it's critical to evaluate their stock before you buy, so you actually understand the risk as well as the opportunity.
Opus Genetics stock quick numbers
Opus Genetics Fundamentals
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
You can see all of the due diligence checks on IRD's stock page.
Is IRD stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge IRD's fair value.
You can access additional valuation research on IRD's stock here.
How do IRD Financials look?
Pros:
- IRD has cash burn of 38986000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the IRD balance sheet.
- IRD has $59.96M in cash and short term investments. This is sufficient to cover its annual cash burn of $38.99M.
Cons:
- Total IRD debt is still negative.
- IRD profit margin has gone down from -429.4% to -892.4% in the past year.
- IRD debt to equity ratio of -1.92 is negative.
- There are more long-term liabilities than short-term assets on the IRD balance sheet.
Do Wall Street analysts think it's a good time to buy IRD stock
Out of 9 sell side analysts who give ratings on IRD, the consensus analyst rating on Opus Genetics is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest IRD Analyst Recommendations
Lili Nsongo, a bottom 13% analyst from Leerink Partners initiates coverage on IRD with a buy rating and announces their IRD price target of $10.00, on May 21, 2026.
Steve Seedhouse, a top 29% analyst from Cantor Fitzgerald initiates coverage on IRD with a strong buy rating and announces their IRD price target of $15.00, on Mar 30, 2026.
Yun Zhong, a bottom 4% analyst from Wedbush maintains IRD with a buy rating and raises their IRD price target from $8.00 to $10.00, on Mar 12, 2026.
Daniil Gataulin, a top 3% analyst from Chardan Capital maintains IRD with a strong buy rating and raises their IRD price target from $9.00 to $11.00, on Mar 12, 2026.
You can dig deeper into what analysts are projecting on the Opus Genetics stock forecast page.
IRD Technical Indicators
Is IRD Making Money?
Last year, IRD revenue was $11.98M. Over the past 4 year, IRD's revenue has increased by 112.38% per year. This was faster than the Biotechnology industry average of 32.37%.
Learn more about IRD's earnings and revenue performance here.
Who is buying/selling IRD?
Over the past 12 months, executives and large shareholders at IRD have sold more shares than they have bought.
Foundation Fighting Blindness Retinal Degeneration Fund, Director of IRD, was the latest IRD insider to sell. They sold $7,395,000.00 worth of IRD shares on May 18, 2026.
Dig into more about who owns IRD stock here.
Does IRD stock generate passive income?
No, Opus Genetics doesn't provide an income stream by paying out dividends.
What do other traders have to say about IRD?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your IRD buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.
Press the Open button and your broker will execute your order.
If you require more info about buying stocks on eToro, watch the how to video below:
Step 6: Get the latest news on your IRD investment
Now that you own some IRD stock, you'll want to keep up with your investment.
Start a watchlist to monitor your IRD stock.
IRD Feed
How to Buy Stock in Opus Genetics
To summarize, here are the 6 steps to buy stock in Opus Genetics:
- Choose where to buy Opus Genetics stock
- Sign up for your brokerage account
- Put funds into your brokerage account
- Research Opus Genetics stock
- Place your IRD buy order
- Get the latest news on your IRD investment
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Opus Genetics, click the button below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.